Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MPC vs GSK✓SelectedUSD · GSKMPC vs GSK performance historyLatest closeAs of-3.00%11/16
Stock and ETF performance explorer

MPC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,136.4%
GSK return
+107.3%
Excess return
+1,029.1%
Maximum drawdown
-79.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.0%-0.1%-2.9%-3.0%
7D+3.2%-1.3%+4.5%+3.6%
30D-15.9%+2.7%-18.6%-16.9%
3M+13.5%+2.7%+10.8%+11.7%
6M+58.7%+3.3%+55.4%+54.6%
YTD+150.2%+6.5%+143.7%+136.6%
1Y+104.5%+10.7%+93.8%+89.8%
3Y+192.5%+64.4%+128.1%+111.0%
5Y+587.3%+46.7%+540.6%+412.3%
10Y+1,136.4%+109.4%+1,027.0%+659.7%
All+1,136.4%+107.3%+1,029.1%+659.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling